Healing Smarter. Fighting Resistance.

Innovative biomaterial solutions
transforming dental and wound care globally.

Who We Are

Innovating Biomaterials for Better Health

AASYA Healthcare is a biomaterials innovation company developing affordable and sustainable healthcare solutions. Our mission is to fight antimicrobial resistance while improving patient comfort and clinical outcomes.

Our Founders

Meet the Visionaries Behind AASYA

Director of Research, Malla Reddy Vishwavidyapeeth, Hyderabad
Dentist, Biomedical Engineer & Entrepreneur

Flagship Innovation – BacNo Gel

Introducing BacNo Gel

BacNo Gel is a patented silk fibroin-based hydrogel embedded with doxycycline, designed for post-extraction wound management.

Localized Action

Delivers antibiotics directly to the wound site, eliminating unnecessary systemic intake.

Improved Comfort

Prevents side effects like gastric irritation, nausea, and diarrhea common with oral antibiotics.

Fights AMR

Reduces over-prescription of antibiotics, addressing the global antimicrobial resistance crisis.

Dual Functionality

Provides antimicrobial protection while creating an osteogenic microenvironment for bone regeneration.

Affordable & Scalable

Designed to be accessible for patients and viable for widespread clinical adoption.

Our Innovation Edge

  • Drug-Induced Hydrogelation – A breakthrough process where doxycycline itself triggers hydrogel formation with silk fibroin.
  • Biocompatibility & Safety – Proven safe and effective in preclinical studies; validated under ISO 10993 protocols.
  • Regenerative Potential – Supports natural bone and tissue healing beyond infection control.
  • Sustainable & Affordable – Uses silk, an abundant biopolymer, making the solution cost-effective and eco-friendly.

Intellectual Property & Global Reach

Innovation Protected & Recognized

  • Granted Indian Patent (2024):Method for Sustained Drug Delivery for Wound Healing Using Silk Hydrogel and Product Thereof
  •  PCT applications filed in USA, UK & China
  • Pipeline innovations in wound care & regenerative medicine.
Our Impact

Why It Matters

  • India witnesses 90+ million tooth extractions annually.
  • Antibiotics are routinely prescribed—even when unnecessary—fueling antimicrobial resistance.
  • BacNo Gel empowers dentists with a safe, effective, and affordable alternative to systemic antibiotics.
  • By cutting down unnecessary antibiotic usage, BacNo Gel contributes to the global fight against AMR and improves patient compliance and comfort.
  • BacNo Gel reduces dependence on systemic antibiotics, empowering dentists and protecting communities worldwide.
Tooth extractions annually in India
0 M+
Unnecessary antibiotic prescriptions
> 0 %
Patients impacted by AMR daily
0 s+

Our Collaborations

Knowledge Partners

Incubation Partners

slide0061_image020

Funding Partners

Clinical Partners

Gallery